Table of Content

Open Access iconOpen Access

REVIEW

crossmark

Mesenchymal stem cell-derived exosome as a nano weapon to target the COVID-19 pandemic

YASHVI SHARMA, SUCHI GUPTA, SUJATA MOHANTY*

Stem Cell Facility (DBT-Centre of Excellence for Stem Cell Research), All India Institute of Medical Sciences, New Delhi, 110029, India

* Address correspondence to: Sujata Mohanty, email

(This article belongs to this Special Issue: Stem Cells, Protein Therapeutics, and Regenerative Medicine)

BIOCELL 2021, 45(3), 517-520. https://doi.org/10.32604/biocell.2021.014621

Abstract

In these times of despair when a nano-sized organism, the SARS-CoV-2, has rendered the human race helpless, made the global health status decline, and drowned the world economy, a ray of hope comes from another nano-sized particle, the exosome. The potential of mesenchymal stem cells has already been established in COVID-19; however, cell-based therapy has its risks. We thereby propose cell-free therapy using stem cells-derived exosomes to fight against COVID-19, as they can be a game-changer owing to their immunomodulatory nature, which combats the cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to therapy worldwide.

Keywords


Cite This Article

SHARMA, Y., GUPTA, S., MOHANTY, S. (2021). Mesenchymal stem cell-derived exosome as a nano weapon to target the COVID-19 pandemic. BIOCELL, 45(3), 517–520. https://doi.org/10.32604/biocell.2021.014621



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2562

    View

  • 1553

    Download

  • 0

    Like

Share Link